isopentenyladenosine has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, M; Honma, Y; Ishii, Y; Ishikura, H; Kiyota, H; Tsumura, H | 1 |
1 other study(ies) available for isopentenyladenosine and Hematologic Malignancies
| Article | Year |
|---|---|
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
Topics: Acetates; Cell Differentiation; Cyclopentanes; Cytokinins; Esters; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; HL-60 Cells; Humans; Isopentenyladenosine; Leukemia; Oxylipins; Tumor Cells, Cultured | 2009 |